Cancer Research Meeting Calendar  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 490-492, February 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muto, M. G.
Right arrow Articles by Berkowitz, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muto, M. G.
Right arrow Articles by Berkowitz, R. S.

Evidence for a Multifocal Origin of Papillary Serous Carcinoma of the Peritoneum1

Michael G. Muto2, William R. Welch, Samuel Chi-Ho Mok, Christina A. Bandera, Paula M. Fishbaugh, Sai-Wah Tsao, Ching C. Lau, Howard M. Goodman, Robert C. Knapp and Ross S. Berkowitz

Laboratory and Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology [M. G. M., S. C-H. M., C. A. B., P. M. F., S-W. T., C. C. L., H. M. G., R. C. K., R. S. B.], and Division of Women's and Perinatal Pathology [W. R. W.], Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115

Histopathological evidence suggests that papillary serous carcinoma of the peritoneum (PSCP) may be multifocal in origin. Utilizing a PCR based method to detect tandem repeat polymorphisms in formalin fixed tissue, loss of heterozygosity at eight loci on chromosomes 1, 3, 4, and 17 was studied in six cases of PSCP. Loss of heterozygosity was assessed at between 5 and 11 tumor sites/patient. Allelic losses at 4 loci (1q32-qter, 3p14.3-21.1, 17q12, 17q21.3-23) were noted. Three cases demonstrated a different pattern of allelic loss at various anatomic sites within the same patient. In an additional case, a mutation of the p53 gene, detected by quantitative PCR followed by single-strand conformation polymorphism analysis, was detected in only 2 of 5 tumor sites. The pattern of allelic loss and the mutational pattern of the p53 gene varied at tumor sites within the same patient in 4 of 6 cases of PSCP. These findings are consistent with histopathological evidence that PSCP is multifocal in origin.

1 Supported in part by a grant from the American Cancer Society and by the William Graves Ovarian Cancer Research Fund, Boston, MA.

2 To whom requests for reprints should be addressed, at Seeley G. Mudd Building, 250 Longwood Avenue, Room 210, Boston, MA 02115.

Received 10/ 7/94. Accepted 12/16/94.




This article has been cited by other articles:


Home page
RadioGraphicsHome page
A. D. Levy, J. Arnaiz, J. C. Shaw, and L. H. Sobin
From the Archives of the AFIP: Primary Peritoneal Tumors: Imaging Features with Pathologic Correlation
RadioGraphics, March 1, 2008; 28(2): 583 - 607.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. N. Landen Jr, M. J. Birrer, and A. K. Sood
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
J. Clin. Oncol., February 20, 2008; 26(6): 995 - 1005.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. K. Demir, F. V. Aker, and N. Koksal
Case 98: Primary Serous Papillary Carcinoma of the Peritoneum
Radiology, September 1, 2006; 240(3): 905 - 909.
[Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
S. X. Liang, S. K. Chambers, L. Cheng, S. Zhang, Y. Zhou, and W. Zheng
Endometrial Glandular Dysplasia: A Putative Precursor Lesion of Uterine Papillary Serous Carcinoma. Part II: Molecular Features
International Journal of Surgical Pathology, October 1, 2004; 12(4): 319 - 331.
[Abstract] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. B. Mills, R. C. Bast Jr., and S. Srivastava
Future for Ovarian Cancer Screening: Novel Markers From Emerging Technologies of Transcriptional Profiling and Proteomics
J Natl Cancer Inst, October 3, 2001; 93(19): 1437 - 1439.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. Gu, L. M. Roth, C. Younger, H. Michael, F. W. Abdul-Karim, S. Zhang, T. M. Ulbright, J. N. Eble, and L. Cheng
Molecular Evidence for the Independent Origin of Extra-ovarian Papillary Serous Tumors of Low Malignant Potential
J Natl Cancer Inst, August 1, 2001; 93(15): 1147 - 1152.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. O. Schorge, M. G. Muto, S. J. Lee, L.-W. Huang, W. R. Welch, D. A. Bell, E. Z. Keung, R. S. Berkowitz, and S. C. Mok
BRCA1-related Papillary Serous Carcinoma of the Peritoneum Has a Unique Molecular Pathogenesis
Cancer Res., March 1, 2000; 60(5): 1361 - 1364.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.